Clinical evaluation of patients with temporomandibular joint implants

Lauren E. Ta, James C. Phero, Stanley R. Pillemer, Hollie Hale-Donze, Nancy McCartney-Francis, Albert Kingman, Mitchell B. Max, Sharon M. Gordon, Sharon M. Wahl, Raymond A. Dionne

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Purpose: An undetermined number of patients with temporomandibular joint (TMJ) symptoms have been treated with intra-articular disc implants composed of Teflon ethylene/propylene or Teflon polytetrafluoroethylene and aluminum oxide (Proplast-Teflon; Vitek, Houston, TX). These implants have shown the potential to fragment in situ resulting in nonbiodegradable particles that stimulate a giant cell reaction and lead to degeneration of local structures, pain, and limitation of mandibular opening. We examined the possible relationship between TMJ implants and persistent pain, responses to sensory stimuli, quality of life, and systemic immune dysfunction. Patients and Methods: This case series (32 patients) were referred from university-based orofacial pain centers and private practices from across the United States. Laboratory and clinical assessments evaluated orofacial pain symptoms, neurologic function, clinical signs and symptoms of rheumatologic disease, physical function, systemic measures of immune function, and behavioral measures. Results: We found that TMJ implant patients appeared to have altered sensitivity to sensory stimuli, a higher number of tender points with a diagnosis of fibromyalgia, increased self-report of chemical sensitivity, higher psychologic distress and significantly lower functional ability. Systemic illness or autoimmune disease was not evident in this series of TMJ implant patients. Conclusions: Significant problems were noted on clinical assessment of TMJ implant patients. This is a US government work. There are no restrictions on its use.

Original languageEnglish (US)
Pages (from-to)1389-1399
Number of pages11
JournalJournal of Oral and Maxillofacial Surgery
Volume60
Issue number12
DOIs
StatePublished - Dec 1 2002
Externally publishedYes

Fingerprint

Temporomandibular Joint
Polytetrafluoroethylene
Facial Pain
Proplast
Pain Clinics
Pain
Aptitude
Fibromyalgia
Private Practice
Giant Cells
Neurologic Manifestations
Self Report
Autoimmune Diseases
Signs and Symptoms
Joints
Quality of Life

ASJC Scopus subject areas

  • Dentistry(all)
  • Surgery

Cite this

Ta, L. E., Phero, J. C., Pillemer, S. R., Hale-Donze, H., McCartney-Francis, N., Kingman, A., ... Dionne, R. A. (2002). Clinical evaluation of patients with temporomandibular joint implants. Journal of Oral and Maxillofacial Surgery, 60(12), 1389-1399. https://doi.org/10.1053/joms.2002.36089

Clinical evaluation of patients with temporomandibular joint implants. / Ta, Lauren E.; Phero, James C.; Pillemer, Stanley R.; Hale-Donze, Hollie; McCartney-Francis, Nancy; Kingman, Albert; Max, Mitchell B.; Gordon, Sharon M.; Wahl, Sharon M.; Dionne, Raymond A.

In: Journal of Oral and Maxillofacial Surgery, Vol. 60, No. 12, 01.12.2002, p. 1389-1399.

Research output: Contribution to journalArticle

Ta, LE, Phero, JC, Pillemer, SR, Hale-Donze, H, McCartney-Francis, N, Kingman, A, Max, MB, Gordon, SM, Wahl, SM & Dionne, RA 2002, 'Clinical evaluation of patients with temporomandibular joint implants', Journal of Oral and Maxillofacial Surgery, vol. 60, no. 12, pp. 1389-1399. https://doi.org/10.1053/joms.2002.36089
Ta LE, Phero JC, Pillemer SR, Hale-Donze H, McCartney-Francis N, Kingman A et al. Clinical evaluation of patients with temporomandibular joint implants. Journal of Oral and Maxillofacial Surgery. 2002 Dec 1;60(12):1389-1399. https://doi.org/10.1053/joms.2002.36089
Ta, Lauren E. ; Phero, James C. ; Pillemer, Stanley R. ; Hale-Donze, Hollie ; McCartney-Francis, Nancy ; Kingman, Albert ; Max, Mitchell B. ; Gordon, Sharon M. ; Wahl, Sharon M. ; Dionne, Raymond A. / Clinical evaluation of patients with temporomandibular joint implants. In: Journal of Oral and Maxillofacial Surgery. 2002 ; Vol. 60, No. 12. pp. 1389-1399.
@article{613a8a2b713a4c499881011a2c040c4e,
title = "Clinical evaluation of patients with temporomandibular joint implants",
abstract = "Purpose: An undetermined number of patients with temporomandibular joint (TMJ) symptoms have been treated with intra-articular disc implants composed of Teflon ethylene/propylene or Teflon polytetrafluoroethylene and aluminum oxide (Proplast-Teflon; Vitek, Houston, TX). These implants have shown the potential to fragment in situ resulting in nonbiodegradable particles that stimulate a giant cell reaction and lead to degeneration of local structures, pain, and limitation of mandibular opening. We examined the possible relationship between TMJ implants and persistent pain, responses to sensory stimuli, quality of life, and systemic immune dysfunction. Patients and Methods: This case series (32 patients) were referred from university-based orofacial pain centers and private practices from across the United States. Laboratory and clinical assessments evaluated orofacial pain symptoms, neurologic function, clinical signs and symptoms of rheumatologic disease, physical function, systemic measures of immune function, and behavioral measures. Results: We found that TMJ implant patients appeared to have altered sensitivity to sensory stimuli, a higher number of tender points with a diagnosis of fibromyalgia, increased self-report of chemical sensitivity, higher psychologic distress and significantly lower functional ability. Systemic illness or autoimmune disease was not evident in this series of TMJ implant patients. Conclusions: Significant problems were noted on clinical assessment of TMJ implant patients. This is a US government work. There are no restrictions on its use.",
author = "Ta, {Lauren E.} and Phero, {James C.} and Pillemer, {Stanley R.} and Hollie Hale-Donze and Nancy McCartney-Francis and Albert Kingman and Max, {Mitchell B.} and Gordon, {Sharon M.} and Wahl, {Sharon M.} and Dionne, {Raymond A.}",
year = "2002",
month = "12",
day = "1",
doi = "10.1053/joms.2002.36089",
language = "English (US)",
volume = "60",
pages = "1389--1399",
journal = "Journal of Oral and Maxillofacial Surgery",
issn = "0278-2391",
publisher = "W.B. Saunders Ltd",
number = "12",

}

TY - JOUR

T1 - Clinical evaluation of patients with temporomandibular joint implants

AU - Ta, Lauren E.

AU - Phero, James C.

AU - Pillemer, Stanley R.

AU - Hale-Donze, Hollie

AU - McCartney-Francis, Nancy

AU - Kingman, Albert

AU - Max, Mitchell B.

AU - Gordon, Sharon M.

AU - Wahl, Sharon M.

AU - Dionne, Raymond A.

PY - 2002/12/1

Y1 - 2002/12/1

N2 - Purpose: An undetermined number of patients with temporomandibular joint (TMJ) symptoms have been treated with intra-articular disc implants composed of Teflon ethylene/propylene or Teflon polytetrafluoroethylene and aluminum oxide (Proplast-Teflon; Vitek, Houston, TX). These implants have shown the potential to fragment in situ resulting in nonbiodegradable particles that stimulate a giant cell reaction and lead to degeneration of local structures, pain, and limitation of mandibular opening. We examined the possible relationship between TMJ implants and persistent pain, responses to sensory stimuli, quality of life, and systemic immune dysfunction. Patients and Methods: This case series (32 patients) were referred from university-based orofacial pain centers and private practices from across the United States. Laboratory and clinical assessments evaluated orofacial pain symptoms, neurologic function, clinical signs and symptoms of rheumatologic disease, physical function, systemic measures of immune function, and behavioral measures. Results: We found that TMJ implant patients appeared to have altered sensitivity to sensory stimuli, a higher number of tender points with a diagnosis of fibromyalgia, increased self-report of chemical sensitivity, higher psychologic distress and significantly lower functional ability. Systemic illness or autoimmune disease was not evident in this series of TMJ implant patients. Conclusions: Significant problems were noted on clinical assessment of TMJ implant patients. This is a US government work. There are no restrictions on its use.

AB - Purpose: An undetermined number of patients with temporomandibular joint (TMJ) symptoms have been treated with intra-articular disc implants composed of Teflon ethylene/propylene or Teflon polytetrafluoroethylene and aluminum oxide (Proplast-Teflon; Vitek, Houston, TX). These implants have shown the potential to fragment in situ resulting in nonbiodegradable particles that stimulate a giant cell reaction and lead to degeneration of local structures, pain, and limitation of mandibular opening. We examined the possible relationship between TMJ implants and persistent pain, responses to sensory stimuli, quality of life, and systemic immune dysfunction. Patients and Methods: This case series (32 patients) were referred from university-based orofacial pain centers and private practices from across the United States. Laboratory and clinical assessments evaluated orofacial pain symptoms, neurologic function, clinical signs and symptoms of rheumatologic disease, physical function, systemic measures of immune function, and behavioral measures. Results: We found that TMJ implant patients appeared to have altered sensitivity to sensory stimuli, a higher number of tender points with a diagnosis of fibromyalgia, increased self-report of chemical sensitivity, higher psychologic distress and significantly lower functional ability. Systemic illness or autoimmune disease was not evident in this series of TMJ implant patients. Conclusions: Significant problems were noted on clinical assessment of TMJ implant patients. This is a US government work. There are no restrictions on its use.

UR - http://www.scopus.com/inward/record.url?scp=0036894406&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036894406&partnerID=8YFLogxK

U2 - 10.1053/joms.2002.36089

DO - 10.1053/joms.2002.36089

M3 - Article

C2 - 12464999

AN - SCOPUS:0036894406

VL - 60

SP - 1389

EP - 1399

JO - Journal of Oral and Maxillofacial Surgery

JF - Journal of Oral and Maxillofacial Surgery

SN - 0278-2391

IS - 12

ER -